Literature DB >> 22377442

Management of intractable epistaxis: endoscopy or nasal packing?

Y Liu1, C Zheng, W Wei, Q Liu.   

Abstract

OBJECTIVES: To investigate common origins of intractable epistaxis, and the efficacy of endoscopic management.
METHODS: Retrospective study of 265 patients with uncontrolled idiopathic epistaxis presenting between July 2008 and July 2009. Patients underwent endoscopic examination and subsequent radiofrequency electrocautery, selective packing or observation.
RESULTS: Nasal endoscopy indicated that the commonest bleeding sources were the superior nasal septum at the olfactory cleft (39.2 per cent), the inferior meatus (27.5 per cent), the sphenoethmoid recess (6.0 per cent), the middle meatus (5.3 per cent) and other locations (3.4 per cent). Bleeding was successfully controlled with nasal endoscopy plus radiofrequency electrocautery or selective packing. In 49 (18.5 per cent) patients, no abnormality was identified; these patients received observation only, and no further bleeding occurred. None of the patients had serious complications or recurrent epistaxis during the three-month follow-up period.
CONCLUSION: Thorough endoscopic examination combined with radiofrequency electrocautery should be used as first-line therapy for intractable epistaxis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22377442     DOI: 10.1017/S0022215112000217

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Analysis of Bleeding Site to Identify Associated Risk Factors of Intractable Epistaxis.

Authors:  Zhenpeng Liao; Jianling Guo; Jiaoping Mi; Wei Liao; Shulin Chen; Yili Huang; Yingxiang Xu; Jun Zhang; Qintai Yang; Haiyu Hong
Journal:  Ther Clin Risk Manag       Date:  2021-08-12       Impact factor: 2.423

2.  A blind area of origins of epistaxis: technical or cognitive?

Authors:  Wei Wei; Yuting Lai; Chaoping Zang; Jiqin Luo; Bijun Zhu; Quan Liu; Ying Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-24       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.